The FDA announced on Dec. 11, 2018, that Enovachem recalled Dyural-40 Injection Kits because the product insert incorrectly stated the stoppers did not contain latex, while they actually do. The agency classified the recall as Class I.
How to tell if you have it
- Brand: Enovachem
- Product: Dyural-40 Injection Kit, 1 Dose, Single Use Only, Rx only
- NDC: 76420-0750-01
- Lots: 050518X5, 051618X1 (Exp 1/31/19); 052318X4 (Exp 5/1/19); 052318X5, 062818X1, 072518X3, 072718X1, 080318X2, 091818X2 (Exp 5/31/19); 082318X4, 083118X1, 090518X4, 091818X4 (Exp 6/30/19); 091818X3 (Exp 7/31/19); 091818X5, 092418X1, 092818X4, 101018X3, 101018X5 (Exp 8/31/19); 102418X5 (Exp 9/30/19)
- Distribution: U.S.A. Nationwide
The hazard
The kits include Sodium Chloride, USP, 0.9%, which was recalled by the manufacturer because the product insert incorrectly stated that the stoppers do not contain latex. The stoppers actually contain natural rubber latex.
Context
Other recent recalls of similar products include Teva Clonidine Transdermal System Recall (2026-03-19), Lupin Liraglutide 18mg/3mL Injection Recall (2026-04-24), and Cipla Lanreotide Injection Recall (2026-03-13).